Inflammatory Bowel Disease (IBD) Clinical Trials

35 recruitingLast updated: June 18, 2026

There are 35 actively recruiting inflammatory bowel disease (ibd) clinical trials across 22 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3. Top locations include Cincinnati, Ohio, United States, New York, New York, United States, Miami, Florida, United States. Updated daily from ClinicalTrials.gov.


Inflammatory Bowel Disease (IBD) Trials at a Glance

35 actively recruiting trials for inflammatory bowel disease (ibd) are listed on ClinicalTrialsFinder across 6 cities in 22 countries. The largest study group is Not Applicable with 12 trials, with the heaviest enrollment activity in Cincinnati, New York, and Miami. Lead sponsors running inflammatory bowel disease (ibd) studies include TIDHI Innovation Inc., Asian Institute of Gastroenterology, India, and Artialis.

Browse inflammatory bowel disease (ibd) trials by phase

Treatments under study

About Inflammatory Bowel Disease (IBD) Clinical Trials

Looking for clinical trials for Inflammatory Bowel Disease (IBD)? There are currently 39 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Inflammatory Bowel Disease (IBD) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Inflammatory Bowel Disease (IBD) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 35 trials

Recruiting

Comparison Diagnostic Tests for the Diagnosis of CYTOmegalovirus Organ Disease in Patients With intestinalBOweL Diseases

Cytomegalovirus (CMV)Inflammatory Bowel Disease (IBD)
IRCCS Azienda Ospedaliero-Universitaria di Bologna200 enrolled1 locationNCT06793124
Recruiting
Not Applicable

AIM-IBD: A Microbiome-Targeted Supplement in Mild-to-Moderate Ulcerative Colitis

ColitisUlcerative Colitis (UC)Inflammatory Bowel Disease (IBD)
ENBIOSIS BIOTECHNOLOGIES162 enrolled1 locationNCT07619638
Recruiting

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

Ulcerative Colitis (UC)Inflammatory Bowel Disease (IBD)Indeterminate Colitis+1 more
University of North Carolina, Chapel Hill200 enrolled9 locationsNCT07237516
Recruiting
Not Applicable

Clinical Investigation of MYIBDDiet App Developed for Inflammatory Bowel Disease (IBD) Patients to Self-manage Their Diet

Inflammatory Bowel Disease (IBD)
University of Alberta40 enrolled1 locationNCT06683105
Recruiting
Phase 2

Study of DISC-0974-201 in Participants With IBD and Anemia

AnemiaInflammatory Bowel Disease (IBD)Inflammatory Bowel Disease (IBD); Anemia
Disc Medicine, Inc21 enrolled9 locationsNCT07368972
Recruiting
Phase 1

A Phase 1 Study of PVT401 in Healthy Subjects

Inflammatory Bowel Disease (IBD)
Parvus Therapeutics, Inc.36 enrolled1 locationNCT07423000
Recruiting
Phase 2

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Crohn's DiseaseUlcerative Colitis (UC)Inflammatory Bowel Disease (IBD)
Mirador Therapeutics, Inc.140 enrolled66 locationsNCT07113522
Recruiting
Not Applicable

Elemental 028 Extra Case Studies

MalabsorptionAllergiesGastrointestinal Disease+3 more
Nutricia UK Ltd30 enrolled1 locationNCT06877923
Recruiting

Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)

Ulcerative Colitis (UC)Crohn Disease (CD)Inflammatory Bowel Disease (IBD)+1 more
TIDHI Innovation Inc.200 enrolled9 locationsNCT07245394
Recruiting
Not Applicable

Setting up a Cohort of Patients With Inflammatory Bowel Disease and a Cohort of Patients Without Chronic Inflammatory Bowel Disease

Inflammatory Bowel Disease (IBD)
Artialis120 enrolled1 locationNCT06502873
Recruiting

Prophylactic Dexamethasone Before Infliximab in Moderate-to-Severe IBD

Inflammatory Bowel Disease (IBD)CD - Crohn's DiseaseUC - Ulcerative Colitis
Second Affiliated Hospital, School of Medicine, Zhejiang University300 enrolled1 locationNCT07385131
Recruiting

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

Traumatic Brain InjuryEhlers-Danlos SyndromePost-Acute COVID-19 Syndrome+41 more
Brain Inflammation Collaborative10,000 enrolled1 locationNCT04806620
Recruiting
Not Applicable

Efficacy of Individualized Aerobic Exercise Training in Patients With Inflammatory Bowel Disease

Inflammatory Bowel Disease (IBD)
Ningbo Medical Center Lihuili Hospital28 enrolled1 locationNCT06804733
Recruiting
Not Applicable

Evaluation of the SMART IBD App in Pediatric IBD

IBD (Inflammatory Bowel Disease)Ulcerative Colitis (UC)Crohn Disease (CD)+3 more
Children's Hospital Medical Center, Cincinnati70 enrolled1 locationNCT07195123
Recruiting

Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD

Ulcerative Colitis (UC)Crohn Disease (CD)Inflammatory Bowel Disease (IBD)+4 more
Connecticut Children's Medical Center120 enrolled1 locationNCT07224113
Recruiting

A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea

Crohn's DiseaseUlcerative ColitisInflammatory Bowel Disease (IBD)
Takeda600 enrolled1 locationNCT05428345
Recruiting

Microplastic Analysis in Pediatric Inflammatory Bowel Disease

Crohn DiseaseUlcerative Colitis (UC)Inflammatory Bowel Disease (IBD)+1 more
Medical University of Gdansk40 enrolled1 locationNCT07141238
Recruiting
Not Applicable

Pilot Study Assessing the Feasibility and Impact of a Remote Adapted Physical Activity Program on Quality of Life in Patients With Inflammatory Bowel Disease (IBD)

Inflammatory Bowel Disease (IBD)Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis)
Raincy Montfermeil Hospital Group72 enrolled2 locationsNCT07191106
Recruiting

Argentine Registry of Crohn's Disease and Ulcerative Colitis

Inflammatory Bowel Disease (IBD)EpidemiologyTherapy
Grupo Argentino de Enfermedad de Crohn y Colitis Ulcerosa4,250 enrolled1 locationNCT07155148
Recruiting

Omics-driven Research on the Gut-Oral Microbiome, Metabolome, Lifestyle, and Clinical Integration in Korean Inflammatory Bowel Disease

Inflammatory Bowel Disease (IBD)
Chang Kyun Lee900 enrolled1 locationNCT06124833